Document ID: chunk:federal_register_of_legislation:F2022C00931:front:0:p4
Version: federal_register_of_legislation:F2022C00931
Segment Type: other
Provision Reference: 
Character Range: 8344–10057

of metals, or a compound containing a metal from the specified list of metals, for a cumulative period of at least 5,000 hours before the clinical onset of anosmia and where that exposure has ceased, the clinical onset of anosmia has occurred within one year of cessation;
            Note: fumes and specified list of metals are defined in the Schedule 1 - Dictionary.
(17)      inhaling fumes from a volatile substance from the specified list of volatile substances for a cumulative period of at least 5,000 hours before the clinical onset of anosmia and where that exposure has ceased, the clinical onset of anosmia has occurred within one year of cessation;
            Note: fumes and specified list of volatile substances are defined in the Schedule 1 - Dictionary.
(18)      experiencing acute, symptomatic poisoning from a neurotoxic substance from the specified list of neurotoxic substances within the 30 days before the clinical onset of anosmia;
            Note: specified list of neurotoxic substances is defined in the Schedule 1 - Dictionary.
(19)      where smoking has not ceased prior to the clinical onset of anosmia, having smoked at least 20 pack-years of tobacco products before the clinical onset of anosmia;
            Note: one pack-year is defined in the Schedule 1 - Dictionary.
(20)      having pellagra at the time of the clinical onset of anosmia;
            Note: pellagra is defined in the Schedule 1 - Dictionary.
(21)      having vitamin B12 deficiency at the time of the clinical onset of anosmia;
(22)      having envenomation by the Australian mulga snake (Pseudoechis australis) or the South African Berg adder (Bitis atropos) at the time of the clinical onset of anosmia.